Position in KYMR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,342,644
+$4,626,698 QoQ
Shares Held
194,843
-8.4% QoQ
Ownership
0.234%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 275 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. KYMR ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in KYMR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,342,644 | 194,843 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $17,715,946 | 212,702 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,321,338 | 274,018 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $21,383,421 | 377,799 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $10,369,079 | 237,605 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $4,709,881 | 172,082 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,645,661 | 239,763 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $23,100,681 | 488,077 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $18,857,374 | 631,738 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $21,995,024 | 547,140 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $11,234,932 | 441,278 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $4,716,654 | 339,328 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $9,331,752 | 405,905 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,668,917 | 326,322 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,935,534 | 237,802 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,760,763 | 172,750 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,579,389 | 334,149 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $7,849,638 | 185,483 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $5,214,114 | 82,125 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,143,329 | 87,561 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,088,867 | 63,688 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $13,629,754 | 350,740 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,083,946 | 17,483 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $149,498 | 4,627 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||